Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORAGENICS INC Director's Dealing 2013

Oct 11, 2013

35380_dirs_2013-10-11_f9a4a402-28be-434c-abee-72a6fabd5efd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (ogen)
CIK: 0001174940
Period of Report: 2013-09-17

Reporting Person: KOSKI FAMILY LP (10% Owner)
Reporting Person: KOSKI CHRISTINE L (Director, 10% Owner)
Reporting Person: KOSKI BEVERLY (10% Owner)
Reporting Person: KOSKI ROBERT C (Director, 10% Owner)
Reporting Person: KOSKI THOMAS L (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-09-17 Common Stock J 604000 Disposed 9163742 Direct
2013-09-17 Common Stock J 200000 Acquired 694147 Direct
2013-09-17 Common Stock J 200000 Acquired 254481 Direct
2013-09-17 Common Stock J 200000 Acquired 669666 Direct
2013-09-17 Common Stock J 4000 Acquired 14000 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 497666 Indirect

Footnotes

F1: On September 17, 2013, the Koski Family Limited Partnership (KFLP) authorized a distribution of 604,000 shares of Oragenics, Inc. common stock to the KFLPs underlying partners: Beverly Koski (through Koski Management, Inc.), Christine L. Koski, Robert C. Koski, and Thomas L. Koski on a pro rata basis, in accordance with their ownership interests in the KFLP.

F2: Shares owned directly by Koski Family Limited Partnership. Shares owned indirectly by Beverly Koski (through Koski Management, Inc. solely owned by Beverly Koski), Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of whom is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.

F3: Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting persons pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

F4: Shares owned directly by Christine L. Koski.

F5: Shares owned directly by Robert C. Koski.

F6: Shares owned directly by Thomas L. Koski.

F7: Shares owned indirectly by Beverly Koski (through Koski Management, Inc).

F8: Shares owned by trusts of which Mr. Robert C. Koski is sole trustee. Such trusts are as follows: the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (100,000 shares); the Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (100,000 shares); the Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (100,000 shares); the Robert Clayton Koski Trust for the benefit of Robert Edward Koski (100,000 shares); and the Robert Clayton Koski Trust for the benefit of Elyse Margaux Koski (97,666 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.